New LiteCure LLC Website Teaches About Photobiomodulation Therapy


LightForce Therapy Laser manufacturer LiteCure LLC announces the launch of its new website focusing on educating users on the science and principles behind photobiomodulation (PBM) therapy.

Features include a glossary of terms; a collection of literature with an emphasis on PBM; veterinary and medical PBM cases, studies, webinars, and whitepapers; an instructive medical animation; and detailed descriptions of each parameter to consider when using light therapy.

The site also features information about LiteCure as a company, such as its core values, community involvement, customer focus, and research support; as well as biographies of the members of LiteCure’s two advisory boards, the company notes in a media release.

For more information and to explore the website, visit LiteCure LLC.

[Source: LiteCure]



Source link

U.S. Physical Therapy, Inc. (USPH) Stake Cut by Guggenheim Capital LLC


Guggenheim Capital LLC decreased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 37.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,571 shares of the company’s stock after selling 8,105 shares during the period. Guggenheim Capital LLC owned about 0.11% of U.S. Physical Therapy worth $953,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Sei Investments Co. increased its stake in U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock valued at $106,000 after buying an additional 911 shares during the last quarter. Acrospire Investment Management LLC increased its stake in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock valued at $115,000 after buying an additional 400 shares during the last quarter. Catalyst Capital Advisors LLC bought a new stake in U.S. Physical Therapy during the third quarter valued at about $154,000. Tyers Asset Management LLC bought a new stake in U.S. Physical Therapy during the fourth quarter valued at about $166,000. Finally, Municipal Employees Retirement System of Michigan increased its stake in U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock valued at $174,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) opened at 63.50 on Wednesday. The firm’s 50-day moving average price is $67.77 and its 200 day moving average price is $66.92. U.S. Physical Therapy, Inc. has a 12-month low of $48.10 and a 12-month high of $78.00. The firm has a market cap of $795.08 million, a P/E ratio of 32.90 and a beta of 0.91.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Stockholders of record on Monday, April 17th will be paid a $0.20 dividend. The ex-dividend date is Wednesday, April 12th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.17. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.26%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 35.05%.

ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Stake Cut by Guggenheim Capital LLC” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/04/19/u-s-physical-therapy-inc-usph-stake-cut-by-guggenheim-capital-llc.html.

Several analysts have issued reports on USPH shares. Zacks Investment Research upgraded U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $79.00 price objective on the stock in a report on Friday, January 6th. Jefferies Group LLC set a $63.00 price objective on U.S. Physical Therapy and gave the stock a “hold” rating in a report on Saturday, March 18th. Finally, Barrington Research downgraded U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, March 17th.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

U.S. PHYSICAL THERAPY INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of U.S. Physical Therapy, Inc.


NEW ORLEANS, April 14, 2017 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into U.S. Physical Therapy, Inc. (NYSE:  USPH).  

On March 16, 2017, U.S. Physical Therapy revealed an accounting error related to “the Company’s historical accounting for redeemable non-controlling interests of acquired partnerships … due to the fact that those partnership agreements contain a provision that makes the non-controlling interests mandatorily redeemable and, thus incorrectly classified.” 

The Company further stated that “this error will result in the reporting of a material weakness in internal controls over financial reporting” requiring “the restatement of previously issued financial statements.”

Thereafter, U.S. Physical Therapy and certain of its executives were sued in a class action lawsuit, charging them with violations of federal securities laws.

KSF’s investigation is focusing on whether U.S. Physical Therapy’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of U.S. Physical Therapy shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC 
Lewis Kahn, Managing Partner 
lewis.kahn@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-physical-therapy-investigation-initiated-by-former-louisiana-attorney-general–kahn-swick–foti-llc-investigates-the-officers-and-directors-of-us-physical-therapy-inc—usph-300439769.html



Source link

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against


The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) U.S. Physical Therapy had a material weakness in its internal controls over accounting and financial reporting; (2) U.S. Physical Therapy improperly accounted for redeemable non-controlling interests of acquired partnerships in violation of Generally Accepted Accounting Principles; (3) U.S. Physical Therapy’s financial statements for the years ended December 31, 2015 and 2014, and all quarters within 2014 and 2015, and the first three quarters of 2016 contained material errors; and (4) consequently, defendants’ statements about U.S. Physical Therapy’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On March 16, 2017, U.S. Physical Therapy revealed that it had discovered an accounting error. The Company stated that “it was determined that the Company’s historical accounting for redeemable non-controlling interests of acquired partnerships was incorrect due to the fact that those partnership agreements contain a provision that makes the non-controlling interests mandatorily redeemable and, thus incorrectly classified.”  U.S. Physical Therapy also said that “[m]anagement has concluded that this error will result in the reporting of a material weakness in internal controls over financial reporting as they relate to this issue and that, as a result, ineffective internal controls over financial reporting. The error will require the restatement of previously issued financial statements.”  Following this news, U.S. Physical Therapy stock has dropped as much as $7.75 per share, or 10.51%, during intraday trading on March 16, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/usph or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in U.S. Physical Therapy you have until May 30, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz–grossman-llc-notifies-investors-of-class-action-against-us-physical-therapy-inc-usph–lead-plaintiff-deadline–may-30-2017-300433552.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

Related Links


http://www.bgandg.com



Source link

The Citadel Advisors LLC Acquires New Stake in U.S. Physical Therapy, Inc. (USPH)


Citadel Advisors LLC acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,461 shares of the company’s stock, valued at approximately $530,000. Citadel Advisors LLC owned approximately 0.07% of U.S. Physical Therapy at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in USPH. Morgan Stanley increased its position in U.S. Physical Therapy by 120.5% in the third quarter. Morgan Stanley now owns 93,266 shares of the company’s stock worth $5,848,000 after buying an additional 50,968 shares during the last quarter. Acrospire Investment Management LLC increased its position in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock worth $115,000 after buying an additional 400 shares during the last quarter. BRYN MAWR TRUST Co increased its position in U.S. Physical Therapy by 1.1% in the third quarter. BRYN MAWR TRUST Co now owns 28,211 shares of the company’s stock worth $1,769,000 after buying an additional 297 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in U.S. Physical Therapy during the third quarter worth approximately $154,000. Finally, King Luther Capital Management Corp increased its position in U.S. Physical Therapy by 2.8% in the third quarter. King Luther Capital Management Corp now owns 36,360 shares of the company’s stock worth $2,280,000 after buying an additional 975 shares during the last quarter. Institutional investors and hedge funds own 97.44% of the company’s stock.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) traded down 0.21% on Wednesday, hitting $70.00. The company’s stock had a trading volume of 58,472 shares. The firm has a market cap of $876.47 million, a PE ratio of 36.27 and a beta of 0.90. The company has a 50 day moving average of $70.33 and a 200 day moving average of $63.84. U.S. Physical Therapy, Inc. has a 1-year low of $45.76 and a 1-year high of $73.05.

A number of research analysts recently issued reports on the company. Zacks Investment Research upgraded U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $79.00 price target on the stock in a research note on Friday, January 6th. Jefferies Group LLC restated a “hold” rating and set a $63.00 price target (up previously from $60.00) on shares of U.S. Physical Therapy in a research note on Monday, December 5th. JMP Securities restated a “hold” rating on shares of U.S. Physical Therapy in a research note on Monday, November 7th. Finally, Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $61.00 price target on the stock in a research note on Friday, November 4th.

In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, December 9th. The stock was sold at an average price of $68.40, for a total transaction of $171,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $58.04, for a total value of $116,080.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,547 shares of company stock worth $659,654. Insiders own 4.30% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).



Source link